John Burn has been appointed as a non-executive director of NHS England, QuantuMDx said this week.
Burn serves as chief medical officer for the Newcastle, UK-based company, which is developing a series of chip-based tests. He also holds the NHS endowed chair in clinical genetics at Newcastle University.
Burn's position as non-executive director of NHS England will take effect from July 1 for a period of four years.
Dutch molecular diagnostics company SkylineDx named its scientific advisory board this week.
Members of SkylineDx's newly formed SAB include Andrzej Jakubowiak, a professor of medicine and director of the Myeloma Program at the University of Chicago; Shaji Kumar, a professor of medicine at the Mayo Clinic College of Medicine; Sagar Lonial, a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and myeloma; Gareth Morgan, director of the Myeloma Institute at the University of Arkansas for Medical Sciences; Antonio Palumbo, chief of the myeloma unit of the department of oncology at the University of Torino in Italy; David Siegel, chief of the division of multiple myeloma at Hackensack University Medical Center; Pieter Sonneveld, head of the department of hematology at Erasmus MC; and Keith Stewart, dean for research at the Mayo Clinic in Arizona.